238 related articles for article (PubMed ID: 25047839)
1. Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state.
Li Z; Li J; Bi P; Lu Y; Burcham G; Elzey BD; Ratliff T; Konieczny SF; Ahmad N; Kuang S; Liu X
Mol Cell Biol; 2014 Oct; 34(19):3642-61. PubMed ID: 25047839
[TBL] [Abstract][Full Text] [Related]
2. Plk1 protein phosphorylates phosphatase and tensin homolog (PTEN) and regulates its mitotic activity during the cell cycle.
Choi BH; Pagano M; Dai W
J Biol Chem; 2014 May; 289(20):14066-74. PubMed ID: 24706748
[TBL] [Abstract][Full Text] [Related]
3. PTEN regulates PLK1 and controls chromosomal stability during cell division.
Zhang Z; Hou SQ; He J; Gu T; Yin Y; Shen WH
Cell Cycle; 2016 Sep; 15(18):2476-85. PubMed ID: 27398835
[TBL] [Abstract][Full Text] [Related]
4. Low-dose arsenic-mediated metabolic shift is associated with activation of Polo-like kinase 1 (Plk1).
Li Z; Lu Y; Ahmad N; Strebhardt K; Liu X
Cell Cycle; 2015; 14(19):3030-9. PubMed ID: 26292025
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction of phosphatase and tensin homologue (PTEN) with the E3 ligase NEDD4-1 during neuronal response to zinc.
Kwak YD; Wang B; Pan W; Xu H; Jiang X; Liao FF
J Biol Chem; 2010 Mar; 285(13):9847-9857. PubMed ID: 20100827
[TBL] [Abstract][Full Text] [Related]
6. Polo-like kinase 1 facilitates loss of Pten tumor suppressor-induced prostate cancer formation.
Liu XS; Song B; Elzey BD; Ratliff TL; Konieczny SF; Cheng L; Ahmad N; Liu X
J Biol Chem; 2011 Oct; 286(41):35795-35800. PubMed ID: 21890624
[TBL] [Abstract][Full Text] [Related]
7. SCF(β-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway.
Liu J; Wan L; Liu P; Inuzuka H; Liu J; Wang Z; Wei W
Oncotarget; 2014 Feb; 5(4):1026-37. PubMed ID: 24657926
[TBL] [Abstract][Full Text] [Related]
8. Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival.
Xiao D; Yue M; Su H; Ren P; Jiang J; Li F; Hu Y; Du H; Liu H; Qing G
Mol Cell; 2016 Nov; 64(3):493-506. PubMed ID: 27773673
[TBL] [Abstract][Full Text] [Related]
9. Interplay between Polo kinase, LKB1-activated NUAK1 kinase, PP1βMYPT1 phosphatase complex and the SCFβTrCP E3 ubiquitin ligase.
Banerjee S; Zagórska A; Deak M; Campbell DG; Prescott AR; Alessi DR
Biochem J; 2014 Jul; 461(2):233-45. PubMed ID: 24785407
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
11. Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma.
Zhao C; Wang B; Liu E; Zhang Z
Cell Commun Signal; 2020 Aug; 18(1):131. PubMed ID: 32831114
[TBL] [Abstract][Full Text] [Related]
12. The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4.
Ahn Y; Hwang CY; Lee SR; Kwon KS; Lee C
Biochem J; 2008 Jun; 412(2):331-8. PubMed ID: 18307411
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin E3 ligase Nedd4-1 acts as a downstream target of PI3K/PTEN-mTORC1 signaling to promote neurite growth.
Hsia HE; Kumar R; Luca R; Takeda M; Courchet J; Nakashima J; Wu S; Goebbels S; An W; Eickholt BJ; Polleux F; Rotin D; Wu H; Rossner MJ; Bagni C; Rhee JS; Brose N; Kawabe H
Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13205-10. PubMed ID: 25157163
[TBL] [Abstract][Full Text] [Related]
14. E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity.
Guo H; Qiao G; Ying H; Li Z; Zhao Y; Liang Y; Yang L; Lipkowitz S; Penninger JM; Langdon WY; Zhang J
Cell Rep; 2012 May; 1(5):472-82. PubMed ID: 22763434
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage.
Tsvetkov L; Stern DF
Cell Cycle; 2005 Jan; 4(1):166-71. PubMed ID: 15611664
[TBL] [Abstract][Full Text] [Related]
16. FoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytes.
Dai B; Pieper RO; Li D; Wei P; Liu M; Woo SY; Aldape KD; Sawaya R; Xie K; Huang S
Cancer Res; 2010 Apr; 70(7):2951-61. PubMed ID: 20332230
[TBL] [Abstract][Full Text] [Related]
17. PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy.
Tan J; Li Z; Lee PL; Guan P; Aau MY; Lee ST; Feng M; Lim CZ; Lee EY; Wee ZN; Lim YC; Karuturi RK; Yu Q
Cancer Discov; 2013 Oct; 3(10):1156-71. PubMed ID: 23887393
[TBL] [Abstract][Full Text] [Related]
18. PLK1/NF-κB feedforward circuit antagonizes the mono-ADP-ribosyltransferase activity of PARP10 and facilitates HCC progression.
Tian L; Yao K; Liu K; Han B; Dong H; Zhao W; Jiang W; Qiu F; Qu L; Wu Z; Zhou B; Zhong M; Zhao J; Qiu X; Zhong L; Guo X; Shi T; Hong X; Lu S
Oncogene; 2020 Apr; 39(15):3145-3162. PubMed ID: 32060423
[TBL] [Abstract][Full Text] [Related]
19. ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway.
Xu D; Wang Y; Wu J; Zhang Z; Chen J; Xie M; Tang R; Chen C; Chen L; Lin S; Luo X; Zheng J
Cell Death Dis; 2021 Feb; 12(2):162. PubMed ID: 33558466
[TBL] [Abstract][Full Text] [Related]
20. Plk1-mediated phosphorylation of Topors regulates p53 stability.
Yang X; Li H; Zhou Z; Wang WH; Deng A; Andrisani O; Liu X
J Biol Chem; 2009 Jul; 284(28):18588-92. PubMed ID: 19473992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
